Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Hryniuk

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Breast Disease|February 3, 2005
Dosage parameters in chemotherapy of breast cancerW Hryniuk
The New England Journal of Medicine|February 25, 1993
CHOP versus m-BACOD in non-Hodgkin's lymphomaW Hryniuk
The Laryngoscope|January 1, 1978
Biochemical pharmacology as it pertains to head and neck cancerW Hryniuk
Cancer Investigation|October 13, 1999
Importance of chemotherapy scheduling: pieces of the puzzleW Hryniuk
Journal of the National Cancer Institute|August 19, 1999
Re: Dose and dose intensity as determinants of outcome in the adjuvant treatment of breast cancerW Hryniuk
The American Journal of Medicine|December 29, 1995
Will increases in dose intensity improve outcome: proW Hryniuk
The Cancer Journal From Scientific American|July 1, 1997
Time for a changeW Hryniuk
Seminars in Oncology|December 1, 1987
The application of dose intensity to problems in chemotherapy of ovarian and endometrial cancerL Levin, W Hryniuk
Lancet (London, England)|September 25, 1971
Cytosine arabinoside and herpes zosterJ Foerster, W Hryniuk
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1984
The importance of dose intensity in chemotherapy of metastatic breast cancerW Hryniuk, H Bush
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Breast Disease|February 3, 2005
Dosage parameters in chemotherapy of breast cancerW Hryniuk
The New England Journal of Medicine|February 25, 1993
CHOP versus m-BACOD in non-Hodgkin's lymphomaW Hryniuk
The Laryngoscope|January 1, 1978
Biochemical pharmacology as it pertains to head and neck cancerW Hryniuk
Cancer Investigation|October 13, 1999
Importance of chemotherapy scheduling: pieces of the puzzleW Hryniuk
Journal of the National Cancer Institute|August 19, 1999
Re: Dose and dose intensity as determinants of outcome in the adjuvant treatment of breast cancerW Hryniuk
The American Journal of Medicine|December 29, 1995
Will increases in dose intensity improve outcome: proW Hryniuk
The Cancer Journal From Scientific American|July 1, 1997
Time for a changeW Hryniuk
Seminars in Oncology|December 1, 1987
The application of dose intensity to problems in chemotherapy of ovarian and endometrial cancerL Levin, W Hryniuk
Lancet (London, England)|September 25, 1971
Cytosine arabinoside and herpes zosterJ Foerster, W Hryniuk
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1984
The importance of dose intensity in chemotherapy of metastatic breast cancerW Hryniuk, H Bush
Pageof 3